Back to Search
LYNDA ROMAN, M.D.
M.D.
Gynecologic Oncology Physician
NPI: 1386649713IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gynecologic Oncology PhysicianPrimary
Obstetrics & Gynecology — Gynecologic Oncology
Code: 207VX0201X
G72001(CA)
Gynecology Physician
Obstetrics & Gynecology — Gynecology
Code: 207VG0400X
G72001(CA)
Education
OTHER
Class of 1984
Research & Publications (20)
A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia.
PMID 17631950·Gynecol Oncol·2007
3-trial
[Comparative clinical evaluation of the effectiveness of modified radical mastectomy and organ-preserving therapy in localized breast cancer (pT1-2N0M0)].
PMID 15088531·Vopr Onkol·2004
4-observational
Who participates in state sponsored Medicaid enhanced prenatal services?
PMID 19085092·Matern Child Health J·2010
8-other
[Quality of life of patients with breast cancer receiving hormonal therapy, depending on age and marital status].
PMID 19670730·Vopr Onkol·2009
8-other
Analogues of 2-aminopyridine-based selective inhibitors of neuronal nitric oxide synthase with increased bioavailability.
PMID 19268602·Bioorg Med Chem·2009
7-preclinical
L337H mutant of rat neuronal nitric oxide synthase resembles human neuronal nitric oxide synthase toward inhibitors.
PMID 19537690·J Med Chem·2009
7-preclinical
Alleviating perinatal depressive symptoms and stress: a nurse-community health worker randomized trial.
PMID 19551471·Arch Womens Ment Health·2009
2-rct
Discovery of highly potent and selective inhibitors of neuronal nitric oxide synthase by fragment hopping.
PMID 19125620·J Med Chem·2009
7-preclinical
Synthesis and enzymatic evaluation of 2- and 4-aminothiazole-based inhibitors of neuronal nitric oxide synthase.
PMID 19590740·Beilstein J Org Chem·2009
8-other
Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsy.
PMID 19235180·Ann Neurol·2009
7-preclinical
Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
PMID 19139430·J Clin Oncol·2009
3-trial
Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia.
PMID 18165643·J Clin Oncol·2008
3-trial
Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab.
PMID 19010874·Clin Cancer Res·2008
3-trial
Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors.
PMID 18321097·J Am Chem Soc·2008
8-other
Deletion of the autoregulatory insert modulates intraprotein electron transfer in rat neuronal nitric oxide synthase.
PMID 18625229·FEBS Lett·2008
7-preclinical
Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
PMID 17762444·Am J Clin Oncol·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 800 FAIRMOUNT AVE, STE 220
PASADENA, CA 91105 - Phone
- (562) 568-1622
Quick Facts
- NPI
- 1386649713
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 42
- Publications
- 20
Are you this provider?
Claim Your Profile